Aviko Radiopharmaceuticals
Company Details
Status: Private
Employees: 1-10
Location:
345 Park Ave S, New York, NY 10010, US
Type:
sample
Technology:
sample
About: Aviko Radiopharmaceuticals is a privately held biotechnology company developing medicines to unlock the potential of boron neutron capture therapy (BNCT) to treat a wide variety of cancers. Aviko's innovative compounds are designed to improve the efficacy of BNCT by targeting and delivering boron to cancer cells with precision. Together with their partners, Aviko is advancing BNCT as a safe, efficacious and convenient treatment modality for patients. Founded by Deerfield Management, Aviko is based at Cure., a healthcare innovation campus in New York City.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Aviko Radiopharmaceuticals | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.